Modern Multidisciplinary Management of Soft Tissue Sarcoma of the Extremity and Trunk.
Shauna R CampbellJoseph R WooleyLukas M NystromPublished in: JCO oncology practice (2024)
Soft tissue sarcomas (STS) of the extremity and trunk are heterogeneous and rare tumors that require coordinated multidisciplinary management. Surgical resection remains the backbone of treatment for localized tumors, with the addition of radiotherapy to surgery to achieve high rates of local control. Despite this, overall survival is limited because of significant distant metastatic risk and a lack of efficacious systemic therapies. Clinical trials have produced conflicting results on the impact of systemic therapy in the neoadjuvant and adjuvant settings for patients with localized disease, leaving systemic treatment decisions largely guided by shared decision making and prognostic prediction tools such as nomograms. This article will review the foundational data as well as latest developments in surgical, radiotherapy, and systemic management supporting current practice guidelines for localized STS of the extremity and trunk.
Keyphrases
- soft tissue
- early stage
- clinical trial
- locally advanced
- lymph node
- squamous cell carcinoma
- minimally invasive
- quality improvement
- rectal cancer
- radiation induced
- stem cells
- combination therapy
- mesenchymal stem cells
- high grade
- electronic health record
- randomized controlled trial
- coronary artery disease
- machine learning
- bone marrow
- smoking cessation